Expression of RET receptor tyrosine kinase and GDNFR-α in normal and leukemic human hematopoietic cells and stromal cells of the bone marrow microenvironment

Blood

Volumn 89, Issue 8, 1997, Pages 2925-2937

  Gattei, Valter ^b   Celetti, Angela ^b   Cerrato, Aniello ^b   Degan, Massimo ^b   De Iuliis, Angela ^b   Rossi, Francesca Maria ^b   Chiappetta, Gennaro ^b   Consales, Claudia ^b   Improta, Salvatore ^b   Zagonel, Vittorina ^b   Aldinucci, Donatella ^b   Agosti, Valter ^b   Santoro, Massimo ^b   Vecchio, Giancarlo ^b   Pinto, Antonio ^b   Grieco, Michele ^a  

^a UNIVERSITY MEDITERRANEA OF REGGIO CALABRIA   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; MESSENGER RNA; ONCOPROTEIN; PROTEIN TYROSINE KINASE;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CELL MATURATION; CONTROLLED STUDY; FIBROBLAST; GENE EXPRESSION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; LEUKEMIA; LYMPHOMA; MONOCYTE; MYELOMONOCYTIC LEUKEMIA; OSTEOBLAST; PRIORITY JOURNAL; STROMA CELL; T LYMPHOCYTE;

ADIPOSE TISSUE; BONE MARROW; CONNECTIVE TISSUE; DROSOPHILA PROTEINS; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, LEUKEMIC; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR RECEPTORS; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKEMIA; LYMPHOCYTE SUBSETS; MYELOPROLIFERATIVE DISORDERS; NEOPLASM PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-RET; RECEPTOR PROTEIN-TYROSINE KINASES; RNA, MESSENGER; RNA, NEOPLASM; TUMOR CELLS, CULTURED; TUMOR STEM CELLS;

EID: 0030896217     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Morrison SJ, Uchida N, Weissman IL: The biology of-hematopoietic stem cells. Annu Rev Cell Dev Biol 11:35, 1995
2. van der Geer P, Hunter T, Lindberg RA: Receptor protein-tyrosine kinases and their signal transduction pathways. Annu Rev Cell Biol 10:251, 1994
3. Fantl WJ, Johnson DE, Williams TW: Signalling by receptor tyrosine kinases. Annu Rev Biochem 62:453, 1993
4. Scherr CJ, Rettenmier CW, Sacca R, Roussel MF, Look AT, Stanley ER: The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1. Cell 41:665, 1985
5. MacDonald BR, Mundy GR, Clark S, Wang EA, Kuehl TJ, Stanley ER, Roodman GD: Effects of human recombinant CSF-GM and highly purified CSF-1 on the formation of multinucleated cells with osteoclast characteristics in long-term bone marrow cultures. J Bone Miner Res 1:227, 1986
6. Galli SJ, Zsebo KM, Geissler EN: The kit ligand, stem cell factor. Adv Immunol 55:1, 1994
7. + human bone marrow cells and is involved in the proliferation of early progenitor/stem cells. Proc Natl Acad Sci USA 91:459, 1994
8. Lyman SD, James L, Johnson L, Brasel K, de Vries P, Escobar S, Downey H, Splett RR, Beckmann MP, McKenna HJ: Cloning of the human homologue of the murine flt3 ligand: A growth factor for early hematopoietic progenitor cells. Blood 83:2795, 1994
9. Gattei V, Aldinucci D, Quinn JMW, Degan M, Cozzi M, Perin V, De Iuliis A, Juzbasic S, Improta S, Athanasou NA, Ashman LK, Pinto A: Human osteoclasts and preosteoclast cells (FLG 29.1) express functional c-kit receptors and interact with osteoblasts and stromal cells via membrane-bound stem cell factor. Cell Growth Diff 7:753, 1996
10. - stem/progenitor cells. Oncogene 12:903, 1996
11. Ehrhard PB, Ganter U, Bauer J, Otten U: Expression of functional TRK proto-oncogene in human monocytes. Proc Natl Acad Sci USA 90:5423, 1993
12. Takahashi M, Buma Y, Iwamoto T, Inaguma Y, Ikeda H, Hiai H: Cloning and expression of the RET proto-oncogene encoding a tyrosine kinase with two potential transmembrane domains. Oncogene 3:571, 1988
13. Schneider R: The human protooncogene RET: A communicative cadherin? Trends Biochem Sci 17:468, 1992
14. Kuma K, Iwabe N, Miyata T: Motifs of cadherin- and fibronectin type III-related sequences and evolution of the receptor-type-protein tyrosine kinases: Sequence similarity between proto-oncogene RET and cadherin family. Mol Biol Evol 10:539, 1993
15. Trupp M, Arenas E, Fainzilber M, Nilsson AS, Sieber BA, Gigoriou M, Kilkenny C, Salazar-Grueso E, Pachnis V, Arumae U, Sariola H, Saarma M, Ibanez CF: Functional receptor for GDNF encoded by the c-RET proto-oncogene. Nature 381:785, 1996
16. Durbec P, Marcos-Gutierrez CV, Kilkenny C, Gigoriou M, Wartiowaara K, Suvanto P, Smith D, Ponder B, Costantini F, Saarma M, Sariola H, Pachnis V: GDNF signalling through the RET receptor tyrosine kinase. Nature 381:789, 1996
17. Lin LFH, Doherty DH, Lile JD, Bektesh S, Collins F: GDNF: A glial cell line-derived neurothropic factor for midbrain dopaminergic neurons. Science 260:1130, 1993
18. Henderson CE, Phillips HS, Pollock RA, Davies AM, Lemeulle C, Armanini M, Simpson LC, Moffet B, Vandlen RA, Koliatsos VE, Rosenthal A: GDNF: A potent survival factor for motoneurons present in the peripheral nerve and muscle. Science 266:1062, 1994
19. Jing S, Wen D, Yu Y, Holst PL, Luo Y, Fang M, Tamir R, Antonio L, Hu Z, Cupples R, Louis JC, Hu S, Altrock BW, Fox, GM: GDNF-induced activation of the RET protein tyrosine kinase is mediated by GDNFR-α, a novel receptor for GDNF. Cell 85:1113, 1996
20. Treanor JJS, Goodman L, de Sauvage F, Stone DM, Poulsen KT, Beck CD, Gray C, Armanini MP, Pollock RA, Hefti F, Phillips HS Goddard A, Moore MW, Buj-Bello A, Davies AM, Asai N, Takahashi M, Vendlen R, Henderson CE, Rosenthal A: Characterization of a multicomponent receptor for GDNF. Nature 382:80, 1996
21. Pachnis V, Mankoo B, Costantini F: Expression of the c-RET proto-oncogene during mouse embryogenesis. Development 119: 1005, 1993
22. Avantaggiato V, Dathan N, Grieco M, Fabien N, Lazzaro D, Fusco A, Simeone A, Santoro M: Developmental expression of the RET proto-oncogene. Cell Growth Diff 5:305, 1994
23. Sanchez MP, Silos-Santiago I, Frisen J, He B, Lira SA, Barbacid M: Renal agenesis and the absence of enteric neurons in mice lacking GDNF. Nature 382:70, 1996
24. Pichel JG, Shen L, Shen HZ, Granholm AC, Drago J, Grinberg A, Lee EJ, Huang SP, Saarma M, Hoffer BJ, Sariola H, Westphal H: Defects in enteric innervation and kidney development in mice lacking GDNF. Nature 382:73, 1996
25. Moore MW, Klein RD, Farinas I, Sauer H, Armanini M, Phillips H, Reichardt LF, Ryan AM, Carver-Moore K, Rosenthal A: Penal and neural abnormalities in mice lacking GDNF. Nature 382:76, 1996
26. Grieco M, Santoro M, Berlingieri MT, Melillo RM, Donghi R, Bongarzone I, Pierotti MA, Della Porta G, Fusco A, Vecchio G: PTC is a novel rearranged form of the RET proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas. Cell 60:557, 1990
27. Flier JS, Underhill LH: The RET proto-oncogene in multiple endocrine neoplasia type 2 and Hirschprung's disease. N Engl J Med 335:943, 1996
28. Tahira T, Ishizaka Y, Itoh F, Nakayasu M, Sugimura T, Nagao M: Expression of the RET proto-oncogene in human neuroblastoma cell lines and its increase during neuronal differentiation induced by RETinoic acid. Oncogene 6:2333, 1991
29. Takahashi M, Cooper GM: RET transforming gene encodes a fusion protein homologous to tyrosine kinases. Mol Cell Biol 7:1378, 1987
30. Takahashi M, Buma Y, Taniguchi, M: Identification of the RET proto-oncogene products in neuroblastoma and leukemia cells. Oncogene 6:297, 1991
31. French-American-British (FAB) Cooperative Group: Proposed revised criteria for the classification of acute myeloid leukemia. Ann Intern Med 103:626, 1985
32. The Non-Hodgkin's Lymphoma Pathologic Classification Project: National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas. Summary and description of a Working Formulation for clinical usage. Cancer 42:2112, 1982
33. van Zaanen HCT, Vet RJWM, de Jong CM, von dem Borne AEGKr, van Oers MHJ: A simple and sensitive method for determining plasma cell isotype and monoclonality in bone marrow using flow cytometry. Br J Haematol 91:55, 1995
34. Manfioletti G, Gattei V, Buratti E, Rustighi A, De Iuliis A, Aldinucci D, Goodwin GH, Pinto A: Differential expression of a novel proline-rich homeobox gene (Prh) in human hematolymphopoietic cells. Blood 85:1237, 1995
35. Carbone A, Gloghini A, Zagonel V, Aldinucci D, Gattei V, Degan M, Improta S, Sorio R, Monfardini S, Pinto A: The expression of CD26 and CD40L is mutually exclusive in human T-cell non-Hodgkin's lymphomas/leukemias. Blood 86:4617, 1995
36. Pinto A, Aldinucci D, Gloghini A, Zagonel V, Degan M, Improta S, Juzbasic S, Todesco M, Perin V, Gattei V, Herrmann F, Gruus HJ, Carbone A: Human eosinophils express functional CD30 ligand and stimulate proliferation of Hodgkin's disease cell line. Blood 88:3299, 1996
37. Gaidano G, Parsa NZ, Tassi V, Della-Latta P, Chaganti RSK, Knowles DM, Dalla Favera R: In vitro establishment of AIDS-related lymphoma cell lines: Phenotypic characterization, oncogene and tumor suppressor gene lesions, and heterogeneity in Epstein-Barr virus infection. Leukemia 7:1621, 1993
38. Testa U, Masciulli R, Tritarelli E, Pastorino R, Mariani G, Martucci R, Barberi T, Camagna A, Valtieri M, Peschle C: Transforming growth factor-b potentiates vitamin D3-induced terminal monocytic differentiation of human leukemic cell lines. J Immunol 150:2418, 1993
39. Chomczynsky P, Sacchi N: Single step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156, 1987
40. Siebert PD, Larrick JW: PCR MIMICs: Competitive DNA fragments for use as internal standards in quantitative PCR. Biotechniques 14:244, 1993
41. Überla K, Pkatzer C, Diamanstein T, Blankenstein T: Generation of competitor DNA fragments for quantitative PCR. PCR Methods Appl 1:136, 1991
42. Carlomagno E, De Vita G, Berlingieri MT, De Franciscis V, Melillo RM, Colantuoni V, Kraus MH, Di Fiore PP, Fusco A, Santoro M: Molecular heterogeneity of RET loss of function in Hirsprung's disease. EMBO J 15:2717, 1996
43. Santoro M, Wong WT, Aroca P, Santos E, Matoskova B, Grieco M, Fusco A, Di Fiore PP: An epidermal growth factor receptor/RET chimera generates mitogenic and transforming signals: Evidence for a RET-specific signaling pathway. Mol Cell Biol 14:663, 1994
44. Pinto A, Aldinucci D, Gattei V, Zagonel V, Tortora G, Budillon A, Cho-Chung YS: Inhibition of the self-renewal capacity of blast progenitors from acute myeloblastic leukemia patients by site-selective 8-chloroadenosine 3′,5′-cyclic monophosphate. Proc Natl Acad Sci USA 89:8884, 1992
45. Pinto A, Attadia V, Fusco A, Ferrara F, Spada OA, Di Fiore PP: 5-aza-2′-deoxycytidine induces terminal differentiation of leukemic blasts from patients with acute myeloid leukemias. Blood 64:922, 1984
46. Taichman RS, Emerson SG: Human osteosarcoma cell lines MG-63 and Saoa-2 produce G-CSF and GM-CSF: Identification and partial characterization of cell-associated isoforms. Exp Hematol 24:509, 1996
47. Tahira T, Ishizaka Y, Sugimura T, Nagao M: Expression of proto-RET mRNA in embryonic and adult rat tissues. Biochem Biophys Res Commun 153:1290, 1988
48. Tsuzuki T, Takahashi M, Asai N, Iwashita T, Matsuyama M, Asai J: Spatial and temporal expression of the RET proto-oncogene in embryonic, infant and adult rat tissues. Oncogene 10:191, 1995
49. Yamaguchi Y, Gunji, Nakamura M, Hayakawa K, Maeda M, Osawa H, Nagayoshi K, Kasahara T, Suda T: Expression of c-kit mRNA and protein during the differentiation of human hematopoietic progenitor cells. Exp Hematol 21:1233, 1993
50. Rosnet O, Schiff C, Pébusque M-J, Marchetto S, Tonnelle C, Toiron Y, Birg F, Birnbaum D: Human FLT3/FLK2 gene: cDNA cloning and expression in hematopoietic cells. Blood 82:1110, 1993
51. Bastard P, Sansilvestri P, Scheinecker C, Knapp W, Debili N, Vainchenker W, Buring H-J, Monier MN, Kukk E, Partanen J, Matikainen M-T, Alitalo R, Hatzfeld J, Alitalo K: The tie receptor tyrosine kinase is expressed by human hematopoietic progenitor cells and by a subset of megakaryocytic cells. Blood 87:2212, 1996
52. Wasserman R, Li Y-S, Hardy RR: Differential expression of the BLK and RET tyrosine kinases during B lineage development is dependent on Ig rearrangement. J Immunol 155:644, 1995
53. Rolink A, Melchers F: Generation and regeneration of cells of the B-lymphocyte lineage. Curr Opin Immunol 5:207, 1993
54. Satterthwaite A, Witte O: Genetic analysis of tyrosine kinase function in B cell development. Annu Rev Immunol 14:131, 1996
55. Muroi K, Nakamura M, Amemiya Y, Suda T, Miura Y: Expression of c-kit receptor (CD117) and CD34 in leukemic cells. Leuk Lymphoma 16:297, 1995
56. Greer JP, Whitlock JA, Mc Kinney: Ki-1 positive anaplastic large cell lymphoma - A useful concept?, in Armitage J, Newland A, Keating A, Burnett A (eds): Haematological Oncology, vol 4. Cambridge Medical Reviews. Cambrige, MA, 1995, p 89
57. Koh HK, Charif M, Weinstock MA: Epidemiology and clinical manifestations of cutaneous T-cell lymphomas. Hematol Oncol Clin North Am 9:943, 1995
58. Santoro M, Rosati R, Grieco M, Berlingieri MT, Colucci-D'Amato L, De Franciscis V, Fusco A: The RET proto-oncogene is consistently expressed in human pheochromocytomas and thyroid medullary carcinomas. Oncogene 5:1595, 1990
59. Visser M, Sonneveld RD, Willemze R, Landegent JE: Haematopoietic growth factor tyrosine kinase receptor expression profiles in normal haematopoiesis. Br J Haematol 94:236, 1996
60. Dickson DW, Mattiace LA, Kure K, Hutchins K, Lyman WD, Bronsan CF: Microglia in human disease, with an emphasis on acquired immune deficiency syndrome. Lab Invest 64:135, 1991
61. Trupp M, Ryden M, Jornvall H, Funakoshi H, Timmusk T, Arenas E, Ibanez CF: Peripheral expression and biological activities of GDNF, a new neurotrophic factor for avian and mammalian peripheral neurons. J Cell Biol 130:137, 1995
62. Wagner JA: Is IL-6 both a cytokine and a neurothropic factor? J Exp Med 183:2417, 1996
63. Shrikant P, Benveniste EN: The central nervous system as an immunocompetent organ. Role of glial cells in antigen presentation. J Immunol 157:1819, 1996